Dongxing Medical Signs Agreement with Academician Deng Zixin's Team at Shanghai Jiao Tong University to Advance Industrialization of Recombinant Humanized Collagen

Product / Tech
โดย 南方财经网·CN·Read original
Summary · why it matters

Dongxing Medical has signed an agreement with the team led by Academician Deng Zixin at Shanghai Jiao Tong University to advance the research, development, and industrialization of recombinant humanized collagen. Leveraging the technology and platform of Deng Zixin's team, Dongxing Medical has completed the development of recombinant humanized type III short-chain and recombinant humanized type III full-length single-chain strains, and has built a 10-ton fermentation production line. The two strains are expected to officially commence production in January 2027.

Impact on stocks 1

© 2026 MarketDXNews